Pharma-Bio Serv (PBSV) Invested Capital (2010 - 2026)

Pharma-Bio Serv (PBSV) has 17 years of Invested Capital data on file, last reported at $10.2 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 14.65% year-over-year to $10.2 million; the trailing twelve-month figure through Jan 2026 stood at $10.2 million (down 14.65% YoY), and the FY2025 full-year result was $11.9 million, down 13.13% from the prior year.
• Invested Capital for Q1 2026 stood at $10.2 million, down from $11.9 million in the prior quarter.
• Across five years, Invested Capital topped out at $17.4 million in Q1 2022 and bottomed at $10.2 million in Q1 2026.
• The 5-year median for Invested Capital is $14.2 million (2024), against an average of $14.4 million.
• The widest annual swing landed in 2022, when Invested Capital slumped 32.26%; it then rose 0.23% in 2023.
• A 5-year view of Invested Capital shows it stood at $16.6 million in 2022, then declined by 2.6% to $16.1 million in 2023, then decreased by 14.95% to $13.7 million in 2024, then dropped by 13.13% to $11.9 million in 2025, then declined by 14.06% to $10.2 million in 2026.
• The last three Invested Capital figures came in at $10.2 million (Q1 2026), $11.9 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.

Peer Comparison